1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Imaging
1.2.3 Molecular
1.2.4 Histology/Cytology
1.2.5 Tumor Marker Immunoassays
1.2.6 POC Colon Cancer Tests
1.3 Market by Application
1.3.1 Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Precision Cancer Diagnostic Tests Market Perspective (2017-2028)
2.2 Precision Cancer Diagnostic Tests Growth Trends by Region
2.2.1 Precision Cancer Diagnostic Tests Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Precision Cancer Diagnostic Tests Historic Market Size by Region (2017-2022)
2.2.3 Precision Cancer Diagnostic Tests Forecasted Market Size by Region (2023-2028)
2.3 Precision Cancer Diagnostic Tests Market Dynamics
2.3.1 Precision Cancer Diagnostic Tests Industry Trends
2.3.2 Precision Cancer Diagnostic Tests Market Drivers
2.3.3 Precision Cancer Diagnostic Tests Market Challenges
2.3.4 Precision Cancer Diagnostic Tests Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Precision Cancer Diagnostic Tests Players by Revenue
3.1.1 Global Top Precision Cancer Diagnostic Tests Players by Revenue (2017-2022)
3.1.2 Global Precision Cancer Diagnostic Tests Revenue Market Share by Players (2017-2022)
3.2 Global Precision Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Precision Cancer Diagnostic Tests Revenue
3.4 Global Precision Cancer Diagnostic Tests Market Concentration Ratio
3.4.1 Global Precision Cancer Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Diagnostic Tests Revenue in 2021
3.5 Precision Cancer Diagnostic Tests Key Players Head office and Area Served
3.6 Key Players Precision Cancer Diagnostic Tests Product Solution and Service
3.7 Date of Enter into Precision Cancer Diagnostic Tests Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Cancer Diagnostic Tests Breakdown Data by Type
4.1 Global Precision Cancer Diagnostic Tests Historic Market Size by Type (2017-2022)
4.2 Global Precision Cancer Diagnostic Tests Forecasted Market Size by Type (2023-2028)
5 Precision Cancer Diagnostic Tests Breakdown Data by Application
5.1 Global Precision Cancer Diagnostic Tests Historic Market Size by Application (2017-2022)
5.2 Global Precision Cancer Diagnostic Tests Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Precision Cancer Diagnostic Tests Market Size (2017-2028)
6.2 North America Precision Cancer Diagnostic Tests Market Size by Type
6.2.1 North America Precision Cancer Diagnostic Tests Market Size by Type (2017-2022)
6.2.2 North America Precision Cancer Diagnostic Tests Market Size by Type (2023-2028)
6.2.3 North America Precision Cancer Diagnostic Tests Market Share by Type (2017-2028)
6.3 North America Precision Cancer Diagnostic Tests Market Size by Application
6.3.1 North America Precision Cancer Diagnostic Tests Market Size by Application (2017-2022)
6.3.2 North America Precision Cancer Diagnostic Tests Market Size by Application (2023-2028)
6.3.3 North America Precision Cancer Diagnostic Tests Market Share by Application (2017-2028)
6.4 North America Precision Cancer Diagnostic Tests Market Size by Country
6.4.1 North America Precision Cancer Diagnostic Tests Market Size by Country (2017-2022)
6.4.2 North America Precision Cancer Diagnostic Tests Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Precision Cancer Diagnostic Tests Market Size (2017-2028)
7.2 Europe Precision Cancer Diagnostic Tests Market Size by Type
7.2.1 Europe Precision Cancer Diagnostic Tests Market Size by Type (2017-2022)
7.2.2 Europe Precision Cancer Diagnostic Tests Market Size by Type (2023-2028)
7.2.3 Europe Precision Cancer Diagnostic Tests Market Share by Type (2017-2028)
7.3 Europe Precision Cancer Diagnostic Tests Market Size by Application
7.3.1 Europe Precision Cancer Diagnostic Tests Market Size by Application (2017-2022)
7.3.2 Europe Precision Cancer Diagnostic Tests Market Size by Application (2023-2028)
7.3.3 Europe Precision Cancer Diagnostic Tests Market Share by Application (2017-2028)
7.4 Europe Precision Cancer Diagnostic Tests Market Size by Country
7.4.1 Europe Precision Cancer Diagnostic Tests Market Size by Country (2017-2022)
7.4.2 Europe Precision Cancer Diagnostic Tests Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Precision Cancer Diagnostic Tests Market Size (2017-2028)
8.2 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Type
8.2.1 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Precision Cancer Diagnostic Tests Market Share by Type (2017-2028)
8.3 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Application
8.3.1 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Precision Cancer Diagnostic Tests Market Share by Application (2017-2028)
8.4 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Region
8.4.1 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Precision Cancer Diagnostic Tests Market Size (2017-2028)
9.2 Latin America Precision Cancer Diagnostic Tests Market Size by Type
9.2.1 Latin America Precision Cancer Diagnostic Tests Market Size by Type (2017-2022)
9.2.2 Latin America Precision Cancer Diagnostic Tests Market Size by Type (2023-2028)
9.2.3 Latin America Precision Cancer Diagnostic Tests Market Share by Type (2017-2028)
9.3 Latin America Precision Cancer Diagnostic Tests Market Size by Application
9.3.1 Latin America Precision Cancer Diagnostic Tests Market Size by Application (2017-2022)
9.3.2 Latin America Precision Cancer Diagnostic Tests Market Size by Application (2023-2028)
9.3.3 Latin America Precision Cancer Diagnostic Tests Market Share by Application (2017-2028)
9.4 Latin America Precision Cancer Diagnostic Tests Market Size by Country
9.4.1 Latin America Precision Cancer Diagnostic Tests Market Size by Country (2017-2022)
9.4.2 Latin America Precision Cancer Diagnostic Tests Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Precision Cancer Diagnostic Tests Market Size (2017-2028)
10.2 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Type
10.2.1 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Precision Cancer Diagnostic Tests Market Share by Type (2017-2028)
10.3 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Application
10.3.1 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Precision Cancer Diagnostic Tests Market Share by Application (2017-2028)
10.4 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Country
10.4.1 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Precision Cancer Diagnostic Tests Introduction
11.1.4 Abbott Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Precision Cancer Diagnostic Tests Introduction
11.2.4 Agilent Technologies Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.2.5 Agilent Technologies Recent Developments
11.3 Becton Dickinson and Company
11.3.1 Becton Dickinson and Company Company Details
11.3.2 Becton Dickinson and Company Business Overview
11.3.3 Becton Dickinson and Company Precision Cancer Diagnostic Tests Introduction
11.3.4 Becton Dickinson and Company Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.3.5 Becton Dickinson and Company Recent Developments
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Details
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Introduction
11.4.4 Bio-Rad Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.4.5 Bio-Rad Laboratories Recent Developments
11.5 Biocartis N.V.
11.5.1 Biocartis N.V. Company Details
11.5.2 Biocartis N.V. Business Overview
11.5.3 Biocartis N.V. Precision Cancer Diagnostic Tests Introduction
11.5.4 Biocartis N.V. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.5.5 Biocartis N.V. Recent Developments
11.6 Biocept
11.6.1 Biocept Company Details
11.6.2 Biocept Business Overview
11.6.3 Biocept Precision Cancer Diagnostic Tests Introduction
11.6.4 Biocept Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.6.5 Biocept Recent Developments
11.7 bioMerieux SA
11.7.1 bioMerieux SA Company Details
11.7.2 bioMerieux SA Business Overview
11.7.3 bioMerieux SA Precision Cancer Diagnostic Tests Introduction
11.7.4 bioMerieux SA Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.7.5 bioMerieux SA Recent Developments
11.8 Canon Medical Systems Corporation
11.8.1 Canon Medical Systems Corporation Company Details
11.8.2 Canon Medical Systems Corporation Business Overview
11.8.3 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Introduction
11.8.4 Canon Medical Systems Corporation Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.8.5 Canon Medical Systems Corporation Recent Developments
11.9 Cynvenio Biosystems
11.9.1 Cynvenio Biosystems Company Details
11.9.2 Cynvenio Biosystems Business Overview
11.9.3 Cynvenio Biosystems Precision Cancer Diagnostic Tests Introduction
11.9.4 Cynvenio Biosystems Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.9.5 Cynvenio Biosystems Recent Developments
11.10 Danaher Corporation
11.10.1 Danaher Corporation Company Details
11.10.2 Danaher Corporation Business Overview
11.10.3 Danaher Corporation Precision Cancer Diagnostic Tests Introduction
11.10.4 Danaher Corporation Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.10.5 Danaher Corporation Recent Developments
11.11 Epigenomics AG
11.11.1 Epigenomics AG Company Details
11.11.2 Epigenomics AG Business Overview
11.11.3 Epigenomics AG Precision Cancer Diagnostic Tests Introduction
11.11.4 Epigenomics AG Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.11.5 Epigenomics AG Recent Developments
11.12 Exosome Diagnostics
11.12.1 Exosome Diagnostics Company Details
11.12.2 Exosome Diagnostics Business Overview
11.12.3 Exosome Diagnostics Precision Cancer Diagnostic Tests Introduction
11.12.4 Exosome Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.12.5 Exosome Diagnostics Recent Developments
11.13 Foundation Medicine
11.13.1 Foundation Medicine Company Details
11.13.2 Foundation Medicine Business Overview
11.13.3 Foundation Medicine Precision Cancer Diagnostic Tests Introduction
11.13.4 Foundation Medicine Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.13.5 Foundation Medicine Recent Developments
11.14 General Electric Company
11.14.1 General Electric Company Company Details
11.14.2 General Electric Company Business Overview
11.14.3 General Electric Company Precision Cancer Diagnostic Tests Introduction
11.14.4 General Electric Company Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.14.5 General Electric Company Recent Developments
11.15 Genomic Health
11.15.1 Genomic Health Company Details
11.15.2 Genomic Health Business Overview
11.15.3 Genomic Health Precision Cancer Diagnostic Tests Introduction
11.15.4 Genomic Health Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.15.5 Genomic Health Recent Developments
11.16 Hologic
11.16.1 Hologic Company Details
11.16.2 Hologic Business Overview
11.16.3 Hologic Precision Cancer Diagnostic Tests Introduction
11.16.4 Hologic Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.16.5 Hologic Recent Developments
11.17 Illumina
11.17.1 Illumina Company Details
11.17.2 Illumina Business Overview
11.17.3 Illumina Precision Cancer Diagnostic Tests Introduction
11.17.4 Illumina Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.17.5 Illumina Recent Developments
11.18 Menarini Silicon Biosystems SpA
11.18.1 Menarini Silicon Biosystems SpA Company Details
11.18.2 Menarini Silicon Biosystems SpA Business Overview
11.18.3 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Introduction
11.18.4 Menarini Silicon Biosystems SpA Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.18.5 Menarini Silicon Biosystems SpA Recent Developments
11.19 Myriad Genetics
11.19.1 Myriad Genetics Company Details
11.19.2 Myriad Genetics Business Overview
11.19.3 Myriad Genetics Precision Cancer Diagnostic Tests Introduction
11.19.4 Myriad Genetics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.19.5 Myriad Genetics Recent Developments
11.20 NanoString Technologies
11.20.1 NanoString Technologies Company Details
11.20.2 NanoString Technologies Business Overview
11.20.3 NanoString Technologies Precision Cancer Diagnostic Tests Introduction
11.20.4 NanoString Technologies Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.20.5 NanoString Technologies Recent Developments
11.21 Ortho Clinical Diagnostics
11.21.1 Ortho Clinical Diagnostics Company Details
11.21.2 Ortho Clinical Diagnostics Business Overview
11.21.3 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Introduction
11.21.4 Ortho Clinical Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.21.5 Ortho Clinical Diagnostics Recent Developments
11.22 QIAGEN N.V.
11.22.1 QIAGEN N.V. Company Details
11.22.2 QIAGEN N.V. Business Overview
11.22.3 QIAGEN N.V. Precision Cancer Diagnostic Tests Introduction
11.22.4 QIAGEN N.V. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.22.5 QIAGEN N.V. Recent Developments
11.23 Randox Laboratories Ltd.
11.23.1 Randox Laboratories Ltd. Company Details
11.23.2 Randox Laboratories Ltd. Business Overview
11.23.3 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Introduction
11.23.4 Randox Laboratories Ltd. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.23.5 Randox Laboratories Ltd. Recent Developments
11.24 Roche Holding AG
11.24.1 Roche Holding AG Company Details
11.24.2 Roche Holding AG Business Overview
11.24.3 Roche Holding AG Precision Cancer Diagnostic Tests Introduction
11.24.4 Roche Holding AG Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.24.5 Roche Holding AG Recent Developments
11.25 Royal Philips N.V.
11.25.1 Royal Philips N.V. Company Details
11.25.2 Royal Philips N.V. Business Overview
11.25.3 Royal Philips N.V. Precision Cancer Diagnostic Tests Introduction
11.25.4 Royal Philips N.V. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.25.5 Royal Philips N.V. Recent Developments
11.26 Siemens AG
11.26.1 Siemens AG Company Details
11.26.2 Siemens AG Business Overview
11.26.3 Siemens AG Precision Cancer Diagnostic Tests Introduction
11.26.4 Siemens AG Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.26.5 Siemens AG Recent Developments
11.27 Thermo Fisher Scientific
11.27.1 Thermo Fisher Scientific Company Details
11.27.2 Thermo Fisher Scientific Business Overview
11.27.3 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Introduction
11.27.4 Thermo Fisher Scientific Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.27.5 Thermo Fisher Scientific Recent Developments
11.28 Vela Diagnostics
11.28.1 Vela Diagnostics Company Details
11.28.2 Vela Diagnostics Business Overview
11.28.3 Vela Diagnostics Precision Cancer Diagnostic Tests Introduction
11.28.4 Vela Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022)
11.28.5 Vela Diagnostics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Imaging
Table 3. Key Players of Molecular
Table 4. Key Players of Histology/Cytology
Table 5. Key Players of Tumor Marker Immunoassays
Table 6. Key Players of POC Colon Cancer Tests
Table 7. Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Precision Cancer Diagnostic Tests Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Precision Cancer Diagnostic Tests Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Precision Cancer Diagnostic Tests Market Share by Region (2017-2022)
Table 11. Global Precision Cancer Diagnostic Tests Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Precision Cancer Diagnostic Tests Market Share by Region (2023-2028)
Table 13. Precision Cancer Diagnostic Tests Market Trends
Table 14. Precision Cancer Diagnostic Tests Market Drivers
Table 15. Precision Cancer Diagnostic Tests Market Challenges
Table 16. Precision Cancer Diagnostic Tests Market Restraints
Table 17. Global Precision Cancer Diagnostic Tests Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Precision Cancer Diagnostic Tests Revenue Share by Players (2017-2022)
Table 19. Global Top Precision Cancer Diagnostic Tests by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Diagnostic Tests as of 2021)
Table 20. Ranking of Global Top Precision Cancer Diagnostic Tests Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Precision Cancer Diagnostic Tests Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Precision Cancer Diagnostic Tests Product Solution and Service
Table 24. Date of Enter into Precision Cancer Diagnostic Tests Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Precision Cancer Diagnostic Tests Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Precision Cancer Diagnostic Tests Revenue Market Share by Type (2017-2022)
Table 28. Global Precision Cancer Diagnostic Tests Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Precision Cancer Diagnostic Tests Revenue Market Share by Type (2023-2028)
Table 30. Global Precision Cancer Diagnostic Tests Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Precision Cancer Diagnostic Tests Revenue Share by Application (2017-2022)
Table 32. Global Precision Cancer Diagnostic Tests Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Precision Cancer Diagnostic Tests Revenue Share by Application (2023-2028)
Table 34. North America Precision Cancer Diagnostic Tests Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Precision Cancer Diagnostic Tests Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Precision Cancer Diagnostic Tests Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Precision Cancer Diagnostic Tests Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Precision Cancer Diagnostic Tests Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Precision Cancer Diagnostic Tests Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Precision Cancer Diagnostic Tests Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Precision Cancer Diagnostic Tests Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Precision Cancer Diagnostic Tests Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Precision Cancer Diagnostic Tests Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Precision Cancer Diagnostic Tests Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Precision Cancer Diagnostic Tests Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Precision Cancer Diagnostic Tests Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Precision Cancer Diagnostic Tests Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Precision Cancer Diagnostic Tests Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Precision Cancer Diagnostic Tests Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Precision Cancer Diagnostic Tests Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Precision Cancer Diagnostic Tests Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Precision Cancer Diagnostic Tests Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Precision Cancer Diagnostic Tests Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Precision Cancer Diagnostic Tests Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Precision Cancer Diagnostic Tests Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Precision Cancer Diagnostic Tests Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Precision Cancer Diagnostic Tests Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Precision Cancer Diagnostic Tests Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Precision Cancer Diagnostic Tests Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Precision Cancer Diagnostic Tests Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Precision Cancer Diagnostic Tests Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Precision Cancer Diagnostic Tests Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Precision Cancer Diagnostic Tests Market Size by Country (2023-2028) & (US$ Million)
Table 64. Abbott Laboratories Company Details
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories Precision Cancer Diagnostic Tests Product
Table 67. Abbott Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 68. Abbott Laboratories Recent Developments
Table 69. Agilent Technologies Company Details
Table 70. Agilent Technologies Business Overview
Table 71. Agilent Technologies Precision Cancer Diagnostic Tests Product
Table 72. Agilent Technologies Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 73. Agilent Technologies Recent Developments
Table 74. Becton Dickinson and Company Company Details
Table 75. Becton Dickinson and Company Business Overview
Table 76. Becton Dickinson and Company Precision Cancer Diagnostic Tests Product
Table 77. Becton Dickinson and Company Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 78. Becton Dickinson and Company Recent Developments
Table 79. Bio-Rad Laboratories Company Details
Table 80. Bio-Rad Laboratories Business Overview
Table 81. Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product
Table 82. Bio-Rad Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 83. Bio-Rad Laboratories Recent Developments
Table 84. Biocartis N.V. Company Details
Table 85. Biocartis N.V. Business Overview
Table 86. Biocartis N.V. Precision Cancer Diagnostic Tests Product
Table 87. Biocartis N.V. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 88. Biocartis N.V. Recent Developments
Table 89. Biocept Company Details
Table 90. Biocept Business Overview
Table 91. Biocept Precision Cancer Diagnostic Tests Product
Table 92. Biocept Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 93. Biocept Recent Developments
Table 94. bioMerieux SA Company Details
Table 95. bioMerieux SA Business Overview
Table 96. bioMerieux SA Precision Cancer Diagnostic Tests Product
Table 97. bioMerieux SA Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 98. bioMerieux SA Recent Developments
Table 99. Canon Medical Systems Corporation Company Details
Table 100. Canon Medical Systems Corporation Business Overview
Table 101. Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product
Table 102. Canon Medical Systems Corporation Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 103. Canon Medical Systems Corporation Recent Developments
Table 104. Cynvenio Biosystems Company Details
Table 105. Cynvenio Biosystems Business Overview
Table 106. Cynvenio Biosystems Precision Cancer Diagnostic Tests Product
Table 107. Cynvenio Biosystems Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 108. Cynvenio Biosystems Recent Developments
Table 109. Danaher Corporation Company Details
Table 110. Danaher Corporation Business Overview
Table 111. Danaher Corporation Precision Cancer Diagnostic Tests Product
Table 112. Danaher Corporation Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 113. Danaher Corporation Recent Developments
Table 114. Epigenomics AG Company Details
Table 115. Epigenomics AG Business Overview
Table 116. Epigenomics AG Precision Cancer Diagnostic Tests Product
Table 117. Epigenomics AG Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 118. Epigenomics AG Recent Developments
Table 119. Exosome Diagnostics Company Details
Table 120. Exosome Diagnostics Business Overview
Table 121. Exosome Diagnostics Precision Cancer Diagnostic Tests Product
Table 122. Exosome Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 123. Exosome Diagnostics Recent Developments
Table 124. Foundation Medicine Company Details
Table 125. Foundation Medicine Business Overview
Table 126. Foundation Medicine Precision Cancer Diagnostic Tests Product
Table 127. Foundation Medicine Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 128. Foundation Medicine Recent Developments
Table 129. General Electric Company Company Details
Table 130. General Electric Company Business Overview
Table 131. General Electric Company Precision Cancer Diagnostic Tests Product
Table 132. General Electric Company Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 133. General Electric Company Recent Developments
Table 134. Genomic Health Company Details
Table 135. Genomic Health Business Overview
Table 136. Genomic Health Precision Cancer Diagnostic Tests Product
Table 137. Genomic Health Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 138. Genomic Health Recent Developments
Table 139. Hologic Company Details
Table 140. Hologic Business Overview
Table 141. Hologic Precision Cancer Diagnostic Tests Product
Table 142. Hologic Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 143. Hologic Recent Developments
Table 144. Illumina Company Details
Table 145. Illumina Business Overview
Table 146. Illumina Precision Cancer Diagnostic Tests Product
Table 147. Illumina Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 148. Illumina Recent Developments
Table 149. Menarini Silicon Biosystems SpA Company Details
Table 150. Menarini Silicon Biosystems SpA Business Overview
Table 151. Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product
Table 152. Menarini Silicon Biosystems SpA Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 153. Menarini Silicon Biosystems SpA Recent Developments
Table 154. Myriad Genetics Company Details
Table 155. Myriad Genetics Business Overview
Table 156. Myriad Genetics Precision Cancer Diagnostic Tests Product
Table 157. Myriad Genetics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 158. Myriad Genetics Recent Developments
Table 159. NanoString Technologies Company Details
Table 160. NanoString Technologies Business Overview
Table 161. NanoString Technologies Precision Cancer Diagnostic Tests Product
Table 162. NanoString Technologies Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 163. NanoString Technologies Recent Developments
Table 164. Ortho Clinical Diagnostics Company Details
Table 165. Ortho Clinical Diagnostics Business Overview
Table 166. Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product
Table 167. Ortho Clinical Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 168. Ortho Clinical Diagnostics Recent Developments
Table 169. QIAGEN N.V. Company Details
Table 170. QIAGEN N.V. Business Overview
Table 171. QIAGEN N.V. Precision Cancer Diagnostic Tests Product
Table 172. QIAGEN N.V. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 173. QIAGEN N.V. Recent Developments
Table 174. Randox Laboratories Ltd. Company Details
Table 175. Randox Laboratories Ltd. Business Overview
Table 176. Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product
Table 177. Randox Laboratories Ltd. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 178. Randox Laboratories Ltd. Recent Developments
Table 179. Roche Holding AG Company Details
Table 180. Roche Holding AG Business Overview
Table 181. Roche Holding AG Precision Cancer Diagnostic Tests Product
Table 182. Roche Holding AG Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 183. Roche Holding AG Recent Developments
Table 184. Royal Philips N.V. Company Details
Table 185. Royal Philips N.V. Business Overview
Table 186. Royal Philips N.V. Precision Cancer Diagnostic Tests Product
Table 187. Royal Philips N.V. Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 188. Royal Philips N.V. Recent Developments
Table 189. Siemens AG Company Details
Table 190. Siemens AG Business Overview
Table 191. Siemens AG Precision Cancer Diagnostic Tests Product
Table 192. Siemens AG Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 193. Siemens AG Recent Developments
Table 194. Thermo Fisher Scientific Company Details
Table 195. Thermo Fisher Scientific Business Overview
Table 196. Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product
Table 197. Thermo Fisher Scientific Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 198. Thermo Fisher Scientific Recent Developments
Table 199. Vela Diagnostics Company Details
Table 200. Vela Diagnostics Business Overview
Table 201. Vela Diagnostics Precision Cancer Diagnostic Tests Product
Table 202. Vela Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2017-2022) & (US$ Million)
Table 203. Vela Diagnostics Recent Developments
Table 204. Research Programs/Design for This Report
Table 205. Key Data Information from Secondary Sources
Table 206. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Precision Cancer Diagnostic Tests Market Share by Type: 2021 VS 2028
Figure 2. Imaging Features
Figure 3. Molecular Features
Figure 4. Histology/Cytology Features
Figure 5. Tumor Marker Immunoassays Features
Figure 6. POC Colon Cancer Tests Features
Figure 7. Global Precision Cancer Diagnostic Tests Market Share by Application: 2021 VS 2028
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Other Case Studies
Figure 11. Precision Cancer Diagnostic Tests Report Years Considered
Figure 12. Global Precision Cancer Diagnostic Tests Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Precision Cancer Diagnostic Tests Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Precision Cancer Diagnostic Tests Market Share by Region: 2021 VS 2028
Figure 15. Global Precision Cancer Diagnostic Tests Market Share by Players in 2021
Figure 16. Global Top Precision Cancer Diagnostic Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Diagnostic Tests as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Precision Cancer Diagnostic Tests Revenue in 2021
Figure 18. North America Precision Cancer Diagnostic Tests Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Precision Cancer Diagnostic Tests Market Size Market Share by Type (2017-2028)
Figure 20. North America Precision Cancer Diagnostic Tests Market Size Market Share by Application (2017-2028)
Figure 21. North America Precision Cancer Diagnostic Tests Market Size Share by Country (2017-2028)
Figure 22. United States Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Precision Cancer Diagnostic Tests Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Precision Cancer Diagnostic Tests Market Size Market Share by Type (2017-2028)
Figure 26. Europe Precision Cancer Diagnostic Tests Market Size Market Share by Application (2017-2028)
Figure 27. Europe Precision Cancer Diagnostic Tests Market Size Share by Country (2017-2028)
Figure 28. Germany Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Precision Cancer Diagnostic Tests Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Precision Cancer Diagnostic Tests Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Precision Cancer Diagnostic Tests Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Precision Cancer Diagnostic Tests Market Size Share by Region (2017-2028)
Figure 38. China Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Precision Cancer Diagnostic Tests Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Precision Cancer Diagnostic Tests Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Precision Cancer Diagnostic Tests Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Precision Cancer Diagnostic Tests Market Size Share by Country (2017-2028)
Figure 48. Mexico Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Precision Cancer Diagnostic Tests Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Precision Cancer Diagnostic Tests Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Precision Cancer Diagnostic Tests Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Precision Cancer Diagnostic Tests Market Size Share by Country (2017-2028)
Figure 54. Turkey Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Precision Cancer Diagnostic Tests Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Abbott Laboratories Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 58. Agilent Technologies Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 59. Becton Dickinson and Company Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 60. Bio-Rad Laboratories Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 61. Biocartis N.V. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 62. Biocept Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 63. bioMerieux SA Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 64. Canon Medical Systems Corporation Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 65. Cynvenio Biosystems Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 66. Danaher Corporation Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 67. Epigenomics AG Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 68. Exosome Diagnostics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 69. Foundation Medicine Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 70. General Electric Company Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 71. Genomic Health Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 72. Hologic Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 73. Illumina Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 74. Menarini Silicon Biosystems SpA Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 75. Myriad Genetics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 76. NanoString Technologies Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 77. Ortho Clinical Diagnostics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 78. QIAGEN N.V. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 79. Randox Laboratories Ltd. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 80. Roche Holding AG Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 81. Royal Philips N.V. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 82. Siemens AG Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 83. Thermo Fisher Scientific Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 84. Vela Diagnostics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2017-2022)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
